By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Activist hedge fund business Starboard Value & Opportunity Fund today said it has delivered a letter to the CEO of Celera expressing concerns about the proposed sale of the company to Quest Diagnostics and asking Celera to renegotiate a better deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.